Neurocrine Biosciences Stocks List
Symbol | Grade | Name | % Change | |
---|---|---|---|---|
NBIX | F | Neurocrine Biosciences, Inc. | -0.93 | |
SPRB | F | Spruce Biosciences, Inc. | -2.40 |
Related Industries: Biotechnology
Symbol | Grade | Name | Weight | |
---|---|---|---|---|
MNTL | F | Tema Neuroscience and Mental Health ETF | 4.06 | |
PBE | D | PowerShares Dynamic Biotech & Genome | 3.89 | |
IBRN | D | iShares Neuroscience and Healthcare ETF | 3.73 | |
FBT | A | First Trust Amex Biotech Index Fund | 2.52 | |
JSMD | B | Janus Small/Mid Cap Growth Alpha ETF | 2.49 |
Compare ETFs
Related Industries:
Biotechnology
- Neurocrine Biosciences
Neurocrine Biosciences is a publicly traded biopharmaceutical company founded in 1992. The company is headquartered in San Diego, California, and led by CEO Kevin Gorman. Neurocrine develops treatments for neurological and endocrine-related diseases and disorders. In 2017, the company's drug valbenazine (Ingrezza) was approved in the US to treat adults with tardive dyskinesia (TD).The company is also developing treatments that are in various stages of clinical research for Parkinson's disease, Tourette syndrome, and congenital adrenal hyperplasia and with a partner for endometriosis and uterine fibroids.
Popular Now
Recent Comments
- LillyMilly1 on LILM
- LillyMilly1 on LILM
- TraderMike on RYDE what a RIDE!!! Holy Crap!
- Crunching_The_Market on RYDE what a RIDE!!! Holy Crap!
- LillyMilly1 on LILM
From the Blog
Featured Articles